A new sulfonylurea called Amaryl (AM-a-ril, glimepiride)

March 1996

A new sulfonylurea called Amaryl (AM-a-ril, glimepiride) will soon hit the market. It's from Hoechst Marion Roussel...the same folks who market DiaBeta (glyburide).

Amaryl works as well as glyburide.

The company will claim that Amaryl causes less hypoglycemia. But the jury is still out on whether this is significant.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote